These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Induction of SENP1 in myocardium contributes to abnormities of mitochondria and cardiomyopathy. Cai R; Gu J; Sun H; Liu X; Mei W; Qi Y; Xue S; Ren S; Rabinowitz JE; Wang Y; Yeh ET; Cheng J J Mol Cell Cardiol; 2015 Feb; 79():115-22. PubMed ID: 25446185 [TBL] [Abstract][Full Text] [Related]
4. Antileukemic effects of topoisomerase I inhibitors mediated by de-SUMOylase SENP1. Niu Q; Hou W; Yan Y; Sun S; Lin Y; Fang H; Ma C; Dong C; Cheng Y; Xu Y; Ding M; Wang S; Cui Z; Chen Y; Li H; Li H; Xiao N Biochim Biophys Acta Mol Basis Dis; 2022 Dec; 1868(12):166492. PubMed ID: 35850175 [TBL] [Abstract][Full Text] [Related]
5. The SUMO protease SENP1 and the chromatin remodeler CHD3 interact and jointly affect chromatin accessibility and gene expression. Rodríguez-Castañeda F; Lemma RB; Cuervo I; Bengtsen M; Moen LM; Ledsaak M; Eskeland R; Gabrielsen OS J Biol Chem; 2018 Oct; 293(40):15439-15454. PubMed ID: 30082317 [TBL] [Abstract][Full Text] [Related]
6. SENP1-mediated NEMO de-SUMOylation inhibits intermittent hypoxia induced inflammatory response of microglia in vitro. Yang T; Sun J; Wei B; Liu S J Cell Physiol; 2020 Apr; 235(4):3529-3538. PubMed ID: 31549402 [TBL] [Abstract][Full Text] [Related]
7. SUMOylation protects against IL-1β-induced apoptosis in INS-1 832/13 cells and human islets. Hajmrle C; Ferdaoussi M; Plummer G; Spigelman AF; Lai K; Manning Fox JE; MacDonald PE Am J Physiol Endocrinol Metab; 2014 Oct; 307(8):E664-73. PubMed ID: 25139051 [TBL] [Abstract][Full Text] [Related]
8. Exploring the desumoylation process of SENP1: a study combined MD simulations with QM/MM calculations on SENP1-SUMO1-RanGAP1. Shi T; Han Y; Li W; Zhao Y; Liu Y; Huang Z; Lu S; Zhang J J Chem Inf Model; 2013 Sep; 53(9):2360-8. PubMed ID: 23930863 [TBL] [Abstract][Full Text] [Related]
9. [SENP1 induced protein deSUMO modification increased the chemotherapy sensitivity of endometrial cancer side population cells]. Yuan ML; Bai J; Li CY; Xue N; Chen XH; Sheng F; Liu XZ; Li P Zhonghua Zhong Liu Za Zhi; 2022 Dec; 44(12):1362-1368. PubMed ID: 36575788 [No Abstract] [Full Text] [Related]
10. SENP1 modulates microglia-mediated neuroinflammation toward intermittent hypoxia-induced cognitive decline through the de-SUMOylation of NEMO. Wang H; Yang T; Sun J; Zhang S; Liu S J Cell Mol Med; 2021 Jul; 25(14):6841-6854. PubMed ID: 34120412 [TBL] [Abstract][Full Text] [Related]
11. The critical role of SENP1-mediated GATA2 deSUMOylation in promoting endothelial activation in graft arteriosclerosis. Qiu C; Wang Y; Zhao H; Qin L; Shi Y; Zhu X; Song L; Zhou X; Chen J; Zhou H; Zhang H; Tellides G; Min W; Yu L Nat Commun; 2017 Jun; 8():15426. PubMed ID: 28569748 [TBL] [Abstract][Full Text] [Related]
12. SENP1 participates in the dynamic regulation of Elk-1 SUMOylation. Witty J; Aguilar-Martinez E; Sharrocks AD Biochem J; 2010 May; 428(2):247-54. PubMed ID: 20337593 [TBL] [Abstract][Full Text] [Related]
13. SENP1 is a crucial promotor for hepatocellular carcinoma through deSUMOylation of UBE2T. Tao Y; Li R; Shen C; Li J; Zhang Q; Ma Z; Wang F; Wang Z Aging (Albany NY); 2020 Jan; 12(2):1563-1576. PubMed ID: 31969492 [TBL] [Abstract][Full Text] [Related]
14. Role of pericyte-derived SENP1 in neuronal injury after brain ischemia. Sun M; Chen X; Yin YX; Gao Y; Zhang L; Chen B; Ji Y; Fukunaga K; Han F; Lu YM CNS Neurosci Ther; 2020 Aug; 26(8):815-828. PubMed ID: 32495523 [TBL] [Abstract][Full Text] [Related]
15. SUMOylation Negatively Regulates Angiogenesis by Targeting Endothelial NOTCH Signaling. Zhu X; Ding S; Qiu C; Shi Y; Song L; Wang Y; Wang Y; Li J; Wang Y; Sun Y; Qin L; Chen J; Simons M; Min W; Yu L Circ Res; 2017 Sep; 121(6):636-649. PubMed ID: 28760777 [TBL] [Abstract][Full Text] [Related]
17. SENP1 deficiency promotes ER stress-induced apoptosis by increasing XBP1 SUMOylation. Jiang Z; Fan Q; Zhang Z; Zou Y; Cai R; Wang Q; Zuo Y; Cheng J Cell Cycle; 2012 Mar; 11(6):1118-22. PubMed ID: 22370484 [TBL] [Abstract][Full Text] [Related]
18. SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia. Cheng J; Kang X; Zhang S; Yeh ET Cell; 2007 Nov; 131(3):584-95. PubMed ID: 17981124 [TBL] [Abstract][Full Text] [Related]
19. Sumoylation Negatively Regulates CSR1-Dependent Prostate Cancer Cell Death. Luo HR; Liu Y; Wan XD; Li JL; Wu M; Zhang QM; Wu DL; Zhao X; Wang TR Cell Physiol Biochem; 2018; 46(5):1861-1867. PubMed ID: 29705808 [TBL] [Abstract][Full Text] [Related]
20. SUMOylation of the ubiquitin ligase IDOL decreases LDL receptor levels and is reversed by SENP1. Wang JQ; Lin ZC; Li LL; Zhang SF; Li WH; Liu W; Song BL; Luo J J Biol Chem; 2021; 296():100032. PubMed ID: 33154164 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]